Quick Heal Technologies confirms full SEBI compliance for FY26

2 min read     Updated on 27 May 2026, 11:50 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Quick Heal Technologies Limited achieved full compliance with SEBI regulations for FY26, with no deviations or penalties recorded. The secretarial audit confirmed adherence to governance standards, policy updates, and disclosure requirements. The company also reported a change in its statutory auditor's firm structure to an LLP.

powered bylight_fuzz_icon
41408415

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies Limited has confirmed full compliance with the Securities and Exchange Board of India (SEBI) regulations for the financial year ended March 31, 2026. A secretarial compliance report filed by Ruchi Bhave, a Practicing Company Secretary, verified that the listed entity adhered to all relevant provisions, including the SEBI Act, 1992, and the Securities Contracts (Regulation) Act, 1956. The review covered various regulations such as the Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, and the Prohibition of Insider Trading Regulations, 2015.

The audit revealed no deviations or non-compliances during the review period. Specifically, the report noted that there were no instances of non-compliance regarding secretarial standards, the adoption and timely updation of policies, or the maintenance and disclosure of information on the company's website. Additionally, no directors were disqualified under Section 164 of the Companies Act, 2013.

Compliance Status and Key Findings

The report detailed the company's adherence to several governance and operational mandates. Quick Heal Technologies confirmed that it does not have any material subsidiaries as of March 31, 2026. The entity also maintained records as prescribed under SEBI regulations and conducted performance evaluations for the Board, Independent Directors, and Committees at the start of the financial year.

Particulars Compliance Status Observations/ Remarks by PCS
Secretarial Standards Yes -
Adoption and updation of Policies Yes -
Maintenance and disclosures on Website Yes -
Disqualification of Director Yes -
Details related to Subsidiaries NA No material subsidiary as on March 31, 2026
Preservation of Documents Yes -
Performance Evaluation Yes -
Related Party Transactions Yes -

Regulatory Actions and Auditor Updates

The certification confirmed that no actions were taken by SEBI or Stock Exchanges against the listed entity, its promoters, directors, or subsidiaries during the review period. Regarding statutory auditors, the report noted that while there were no resignations, the firm M S K A & Associates converted into a Limited Liability Partnership named M S K A & Associates LLP effective January 13, 2026.

The company also complied with disclosure requirements for Employee Benefit Scheme Documents under Regulation 46(2)(za) of the SEBI (LODR) Regulations, 2015. The report emphasized that the responsibility for compliance and authenticity of documents lies with the management, while the certification is based on an examination of relevant records and is neither an audit nor an expression of opinion on financial viability.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-2.66%-12.25%+10.75%-38.30%-35.42%-19.03%

How will Quick Heal Technologies leverage its strong governance framework to support future expansion or acquisition strategies?

What impact will the auditor's conversion to an LLP have on the company's financial reporting processes for the upcoming fiscal year?

Does the absence of material subsidiaries indicate a strategic shift towards organic growth rather than inorganic expansion?

Quick Heal Technologies
View Company Insights
View All News
like16
dislike

Quick Heal Reports FY26 Net Loss of INR 10.93 Cr

2 min read     Updated on 23 May 2026, 12:53 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Quick Heal Technologies announced its audited financial results for the quarter and year ended March 31, 2026, reporting a net loss of INR 10.93 Cr for the full year compared to a net profit of INR 5.04 Cr in the previous year. For Q4 FY26, the company recorded a net loss of INR 19.94 Cr on a standalone basis and INR 199M on a consolidated basis, with revenue declining to INR 48.73 Cr and INR 487M respectively. The Board approved the results on May 21, 2026, and the outcome was published in newspapers on May 23, 2026.

powered bylight_fuzz_icon
40375983

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies has announced its audited financial results for the fourth quarter and financial year ended March 31, 2026. The Board of Directors approved the audited standalone and consolidated financial results at its meeting held on May 21, 2026. M S K A & Associates LLP, Statutory Auditors, issued an audit report with an unmodified opinion on the results. The company published the outcome of the board meeting in newspapers including the Financial Express and Prabhat on May 23, 2026.

Financial Performance

For the quarter ended March 31, 2026, the company reported a revenue from operations of INR 48.73 Cr. Total income for the quarter stood at INR 52.48 Cr. The company incurred a total expense of INR 82.15 Cr, resulting in a loss before tax of INR 29.67 Cr. After accounting for a deferred tax benefit of INR 9.73 Cr, the company reported a net loss of INR 19.94 Cr for the quarter. The basic and diluted earnings per share (EPS) for the quarter were INR (3.58) and INR (3.56) respectively.

On a consolidated basis, the company reported a net loss of INR 199M for Q4, compared to a net loss of INR 33M in the same quarter of the previous year. Consolidated revenue for the quarter stood at INR 487M, against INR 651M in the year-ago period, reflecting a year-on-year decline.

For the full year ended March 31, 2026, revenue from operations was INR 261.02 Cr, compared to INR 279.53 Cr in the previous year. Total income for the year was INR 283.85 Cr. Total expenses increased to INR 304.49 Cr from INR 299.30 Cr in the prior year. The company reported a net loss of INR 10.93 Cr for the year, a decrease from the net profit of INR 5.04 Cr recorded in the previous year. The basic and diluted EPS for the year were INR (1.98) and INR (1.96) respectively.

Key Financial Metrics

The following table summarises the standalone financial performance for the quarter and year ended March 31, 2026, alongside consolidated Q4 year-on-year comparisons:

Parameter: Q4 FY26 (INR Cr) FY26 (INR Cr)
Revenue from Operations 48.73 261.02
Total Income 52.48 283.85
Total Expenses 82.15 304.49
Profit/(Loss) Before Tax (29.67) (20.64)
Net Profit/(Loss) (19.94) (10.93)
Basic EPS (3.58) (1.98)

The consolidated Q4 year-on-year performance is presented below:

Metric: Q4 FY26 Q4 FY25
Revenue INR 487M INR 651M
Net Profit/(Loss) INR (199M) INR (33M)

Management Appointments

The Board appointed Mr. Rohit Kachroo as Senior Management Personnel effective May 21, 2026. Mr. Kachroo brings over 18 years of experience in IT transformation, service delivery, and automation. He was previously associated with TopSource Worldwide as Head of Transformation & IT.

Segment Reporting

The company continues to operate as a single reportable segment, cybersecurity platform, as defined by Ind AS 108. Revenue from India for the year ended March 31, 2026, was INR 242.26 Cr, while revenue from outside India was INR 18.76 Cr.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-2.66%-12.25%+10.75%-38.30%-35.42%-19.03%

What specific turnaround strategies is Quick Heal's management planning to reverse the trend from a net profit of INR 5.04 Cr in FY25 to a net loss of INR 10.93 Cr in FY26?

Given the significant revenue decline from INR 651M to INR 487M in Q4 year-on-year, how might Quick Heal reposition its cybersecurity offerings to compete against global players like CrowdStrike and Palo Alto Networks entering the Indian market?

With international revenue accounting for only INR 18.76 Cr out of INR 261.02 Cr total, what is Quick Heal's roadmap for expanding its global footprint to reduce dependence on the domestic market?

Quick Heal Technologies
View Company Insights
View All News
like18
dislike

More News on Quick Heal Technologies

1 Year Returns:-35.42%